GLP1R-targeting drugs dominate type 2 diabetes pipeline: GlobalData EP News Bureau Nov 7, 2023 This indicates a shift from the conventional IR to the GLP1R as the primary target for pioneering T2D treatments
COVID-19 to have long-term impact on global diabetes market: GlobalData EP News Bureau May 22, 2021 As diabetes case numbers are expected to be further fuelled by COVID-19, and as the pathophysiology of COVID-19 induced diabetes…